AngioDynamics

AngioDynamics AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by

AngioDynamics’ history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach. Queensbury was chosen due to its location in the heart of "Catheter Valley," an area in New York's Adirondack Region named for its long history of catheter and other medical device manufacturin

g. Today, the Company has made its presence apparent far beyond Upstate New York with 1,300 employees worldwide at facilities in the United States, Europe, and Asia. AngioDynamics is currently selling in more than 50 markets through direct sales and distributors. Initially dedicated to the research and development of products used in interventional radiology, the Company soon became well established as a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. Through acquisitions of companies such as RITA Medical Systems in January 2007, Oncobionic in May 2008, and the assets of Diomed in June 2008 and FlowMedica in January 2009, AngioDynamics now boasts a diverse product line that includes market-leading thermal and non-thermal ablation systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, venous products and targeted renal therapy products. Continuing its expansion, in May 2012, AngioDynamics acquired Navilyst Medical, bringing market-leading fluid management systems into its portfolio. The acquisition significantly expanded the Company's scale, doubling its share of the vascular access market while building critical mass in the peripheral vascular market. A comprehensive look at the Company's history can be found in the form of an interactive timeline of events at www.angiodynamics.com.

Congratulations to this year's President's Club inductees! Thank you for your dedication to AngioDynamics and showing yo...
06/17/2026

Congratulations to this year's President's Club inductees! Thank you for your dedication to AngioDynamics and showing your team what it means to be mission-ready.

Kelly Pittman
Jason Scocchera
Mark Weser
Matt Harris
Duane Anderson
Jaclene Corstorphine
Chloe Kimmey
Adnan Khan
Marcus Smith
Alicia Painter
Dean Rutledge
Bradd Mellion
Nathan Cochran
Greg Walker
Brooke Cooksey
Erick Brantley
Mandy Tharp
Ali Densmore
Tom Miller
Carrie Hutton
Jeff Oestereich
Ben Pincus
Tim Snider
Jared Rochelle
Cliff Lane
Kyle Kersey
Elizabeth Hancock
Laura Stout
Pete Makula
Chantal Souligny
Gilberto Bregantim
Kizy Sorato Tavares
Ryan Tracy
KerryAnn Thompson
Kelly Deerfield
Margeaux Hayden

We are excited to launch our annual Global Sales Meeting (GSM) this Thursday. This event will bring together leadership,...
06/10/2026

We are excited to launch our annual Global Sales Meeting (GSM) this Thursday. This event will bring together leadership, sales, clinical, and marketing teams from all regions to collaborate, reflect on last year’s performance, and develop strategies for the upcoming year aimed at strengthening physician partnerships and improving patient care.

The theme “All Systems Go” is the signal that preparation has met opportunity. Just like a successful space launch, every system matters — our people, our strategy, our innovation, and our ex*****on. When we are aligned and mission-ready, there’s no limit to how far we can go.

Stay tuned to our social profiles to hear more from GSM!

For over 30 years, Soft-Vu Angiographic Catheters have been a trusted choice for physicians. Visit our website or connec...
05/26/2026

For over 30 years, Soft-Vu Angiographic Catheters have been a trusted choice for physicians. Visit our website or connect with a sales representative to learn more about what sets Soft-Vu apart from other angiographic catheters.

Visit us: https://bit.ly/3OgShzQ
Risk info: https://bit.ly/3UFe4Rf

05/20/2026

Thoughtful design and dependable access for long-term therapy - the BioFlo implantable port with Endexo technology.

Visit us: BioFlo Ports | AngioDynamics

Risk info: Medical Technologies and Devices Risk Information | AngioDynamics



1. The reduction in thrombus accumulation (based on platelet count) is supported by acute in-vitro testing. Pre-clinical in-vitro evaluations do not necessarily predict clinical performance with respect to thrombus formation.
2. Based on benchtop testing performed up to two hours using bovine blood, which may not be indicative of clinical results. Data on file.

05/07/2026

SmartPort+ implantable ports with Endexo technology have the potential to reduce thrombus, fibrin sheath, and clot formations, potentially leading to lower procedural costs and improved patient outcomes.

Make the switch to SmartPort+ implantable ports and see the difference.

For full risk information, please visit: www.angiodynamics.com/about-us/risk-information.

+

We pause to recognize the unwavering dedication, compassion, and expertise nurses bring to healthcare every day. Your co...
05/06/2026

We pause to recognize the unwavering dedication, compassion, and expertise nurses bring to healthcare every day. Your commitment to patients and the resilience you show in every challenge inspire all of us.

We’re honored to support your work with innovative medical devices that help empower the care you deliver.

Thank you. This week and always, we celebrate you.

Address

14 Plaza Drive
Latham, NY
12110

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+15187951400

Alerts

Be the first to know and let us send you an email when AngioDynamics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to AngioDynamics:

Share